HealthEquity, Inc. (HQY)
- Previous Close
79.04 - Open
78.64 - Bid 79.23 x 200
- Ask 79.60 x 100
- Day's Range
78.40 - 79.79 - 52 Week Range
48.86 - 84.49 - Volume
31,757 - Avg. Volume
551,191 - Market Cap (intraday)
6.842B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
124.08 - EPS (TTM)
0.64 - Earnings Date Jun 3, 2024 - Jun 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
99.23
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
www.healthequity.com3,126
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: HQY
Performance Overview: HQY
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HQY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HQY
Valuation Measures
Market Cap
6.81B
Enterprise Value
7.34B
Trailing P/E
123.50
Forward P/E
42.02
PEG Ratio (5yr expected)
2.27
Price/Sales (ttm)
6.88
Price/Book (mrq)
3.35
Enterprise Value/Revenue
7.34
Enterprise Value/EBITDA
25.88
Financial Highlights
Profitability and Income Statement
Profit Margin
5.57%
Return on Assets (ttm)
2.56%
Return on Equity (ttm)
2.84%
Revenue (ttm)
999.59M
Net Income Avi to Common (ttm)
55.71M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
403.98M
Total Debt/Equity (mrq)
45.85%
Levered Free Cash Flow (ttm)
211.89M
Research Analysis: HQY
Company Insights: HQY
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: HQY
HQY: What does Argus have to say about HQY?
HEALTHEQUITY INC has an Investment Rating of HOLD; a target price of $84.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetHQY: Raising target price to $84.00
HEALTHEQUITY INC has an Investment Rating of HOLD; a target price of $84.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetHQY: Lowering target price to $83.00
HEALTHEQUITY INC has an Investment Rating of HOLD; a target price of $83.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetHQY: Raising target price to $87.00
HEALTHEQUITY INC has an Investment Rating of HOLD; a target price of $87.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target